cIAP-1

Cellular inhibitor of apoptosis protein 1 (cIAP1, BIRC2) is a multifunctional E3 ubiquitin ligase of the inhibitor of apoptosis protein family that primarily regulates signal transduction rather than directly blocking caspases^[1][2]. Through its RING-dependent ubiquitin ligase activity, cIAP1 controls the assembly, stability, and turnover of signaling complexes, thereby shaping cellular responses to stress, inflammation, and immune stimulation^[1][3]. Mechanistically, cIAP1 is a central regulator of TNF receptor (TNFR) signaling and NF-κB pathways, where it promotes ubiquitination of receptor-associated signaling proteins, including RIP1, to support pro-survival and inflammatory signaling outputs^[3]. cIAP1 also contributes to innate immune regulation through TNFR superfamily members, cytokine receptors, and pattern-recognition receptor pathways, linking ubiquitin signaling to immune homeostasis^[1]. In disease models, disruption of cIAP1 activity alters cell-death regulation and NF-κB signaling, while combined loss of cIAP1 and cIAP2 enhances pathological responses associated with dysregulated non-canonical NF-κB activation and tissue inflammation^[2]. Compared with the related isoforms XIAP and cIAP2, cIAP1 is distinguished by its prominent role in receptor-proximal ubiquitin signaling networks and its ability to cooperate with, yet remain functionally nonredundant from, cIAP2 in maintaining signaling homeostasis^[1][2]. For experimental applications, SMAC mimetics induce rapid cIAP1 degradation and are widely used to investigate TNF-dependent signaling, NF-κB regulation, ubiquitin-mediated signal transduction, and regulated cell-death mechanisms^[1][4].